My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 339

    1.

    Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice.

    Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, Accili D.

    Diabetes. 2007 Aug;56(8):1969-76. Epub 2007 May 2.PMID: 17475934 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice.

    Bauche IB, Ait El Mkadem S, Rezsohazy R, Funahashi T, Maeda N, Miranda LM, Brichard SM.

    Biochem Biophys Res Commun. 2006 Jul 14;345(4):1414-24. Epub 2006 May 15.PMID: 16729974 [PubMed - indexed for MEDLINE]Related articles

    3.

    Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.

    Andreelli F, Foretz M, Knauf C, Cani PD, Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, Vaulont S, Burcelin R, Viollet B.

    Endocrinology. 2006 May;147(5):2432-41. Epub 2006 Feb 2.PMID: 16455782 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.

    Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M.

    Endocrinology. 2006 Sep;147(9):4517-24. Epub 2006 Jun 1.PMID: 16740970 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.

    Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, DeFronzo RA.

    Diabetologia. 2007 Aug;50(8):1723-31. Epub 2007 May 23.PMID: 17520238 [PubMed - indexed for MEDLINE]Related articles

    6.

    Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.

    Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB.

    Diabetes. 2006 Sep;55(9):2562-70.PMID: 16936205 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo.

    Neschen S, Katterle Y, Richter J, Augustin R, Scherneck S, Mirhashemi F, Schürmann A, Joost HG, Klaus S.

    Physiol Genomics. 2008 May 13;33(3):333-40. Epub 2008 Mar 18.PMID: 18349383 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.

    Tsuchida A, Yamauchi T, Takekawa S, Hada Y, Ito Y, Maki T, Kadowaki T.

    Diabetes. 2005 Dec;54(12):3358-70.PMID: 16306350 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Adiponectin and adiponectin receptors.

    Kadowaki T, Yamauchi T.

    Endocr Rev. 2005 May;26(3):439-51. Review.PMID: 15897298 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    beta-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-alpha expression in adipocytes.

    Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y.

    Eur J Pharmacol. 2007 Aug 13;569(1-2):155-62. Epub 2007 May 13.PMID: 17574233 [PubMed - indexed for MEDLINE]Related articles

    11.

    Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.

    Hazel M, Cooksey RC, Jones D, Parker G, Neidigh JL, Witherbee B, Gulve EA, McClain DA.

    Endocrinology. 2004 May;145(5):2118-28. Epub 2003 Dec 18.PMID: 14684615 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway.

    Bae EJ, Yang YM, Kim JW, Kim SG.

    Hepatology. 2007 Sep;46(3):730-9.PMID: 17668885 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats.

    Rodríguez A, Catalán V, Becerril S, Gil MJ, Mugueta C, Gómez-Ambrosi J, Frühbeck G.

    Life Sci. 2008 Oct 10;83(15-16):540-9. Epub 2008 Aug 14.PMID: 18761357 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts.

    Fang X, Palanivel R, Zhou X, Liu Y, Xu A, Wang Y, Sweeney G.

    J Mol Endocrinol. 2005 Dec;35(3):465-76.PMID: 16326833 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.

    Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T.

    J Biol Chem. 2006 Mar 31;281(13):8748-55. Epub 2006 Jan 23.PMID: 16431926 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats.

    Guo Z, Xia Z, Yuen VG, McNeill JH.

    Metabolism. 2007 Oct;56(10):1363-71.PMID: 17884446 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.

    Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T.

    Hepatology. 2008 Aug;48(2):458-73.PMID: 18666257 [PubMed - indexed for MEDLINE]Related articles

    18.

    Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.

    Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T.

    Cell Metab. 2007 Jul;6(1):55-68.PMID: 17618856 [PubMed - indexed for MEDLINE]Related articles

    19.

    Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training.

    Blüher M, Bullen JW Jr, Lee JH, Kralisch S, Fasshauer M, Klöting N, Niebauer J, Schön MR, Williams CJ, Mantzoros CS.

    J Clin Endocrinol Metab. 2006 Jun;91(6):2310-6. Epub 2006 Mar 21.PMID: 16551730 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.

    Ide T, Tsunoda M, Mochizuki T, Murakami K.

    Med Sci Monit. 2004 Oct;10(10):BR388-95. Epub 2004 Sep 23.PMID: 15448592 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity